2019 European Thyroid Association Guidelines on the Management of Thyroid Dysfunction following Immune Reconstitution Therapy
Ilaria Muller(University of Milan), Colin Dayan(University of Birmingham), Brigitte Decallonne(KU Leuven), Beatriz Lecumberri(Hospital Universitario La Paz), Joanne Jones(University of Cambridge), Carla Moran(University College Dublin), Neil P. Robertson(Cardiff University)
Cited by 76
Related Papers
A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
|Nature Genetics|1996|647
High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease
|Annals of Internal Medicine|2012|362
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement
|Nature Reviews Endocrinology|2018|346
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)
|Journal of Clinical Investigation|2009|299
Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients
|Endocrine Related Cancer|2015|204